Previous studies have shown that individuals living with HIV are at higher risk for heart disease than individuals without HIV
Andrea Aguayo, PharmD
Advertisement
Articles by Andrea Aguayo, PharmD
A notable revision now includes a dual GIP and GLP-1 receptor agonist (tirzepatide) as an additional option for glycemic management, preferred over insulin.
This latest revision introduces a new set of drug criteria, refines the existing ones, and enhances the overall formatting to ensure increased ease of use and clarity for its recommendations.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
3
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
4
Recognizing Immunizing Pharmacists in the Community
5
